Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
35,000-square-foot facility for clinical drug substance manufacturing of antibodies and recombinant proteins.
November 8, 2022
By: Tim Wright
Editor-in-Chief, Contract Pharma
Contract development and manufacturing organization (CDMO) Wheeler Bio and CRB, a provider of sustainable engineering, architectural, construction and consulting services to the life sciences industry, have started construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM). Wheeler is the newest member of Oklahoma City’s biotech hub. Housed in the ultra-modern Ziggurat building located in downtown OKC, Wheeler is making no compromises in establishing state-of-the-art biomanufacturing in their 35,000-square-foot brownfield space. With closed processing and ballroom designs engineered by CRB and cleanroom construction partners, Lingo Construction Services, Inc., Wheeler is capitalizing on the latest innovations in cleanroom concepts allowing for agility that will better serve the needs of the early clinical phase developers. “I am thrilled to announce the kick-off of our latest capital project to establish Wheeler’s first GMP drug substance manufacturing capability in Oklahoma City,” said Jesse McCool, CEO of Wheeler Bio. “The caliber of collaboration so far among stakeholders including Wheeler, CRB, and Lingo has been truly impressive resulting in a detailed design that is a perfect reflection of our vision of an agile, phase appropriate, ‘smart factory’.” Yuk Chun Chiu, CMO of Wheeler, said, “This design gives us the ultimate flexibility in manufacturing operations while maintaining quality and regulatory compliance. We are excited to provide the best-in-class CDMO services through our modern facility design, robust risk management, and advanced automation infrastructures.” Ashley Reynolds, market team leader of CRB, said, “As the prominence of biologics grows in the global fight against viruses and disease, we’re honored to work alongside Wheeler in providing flexible spaces that can support the continued evolution of this important work.” Once complete, the facility will include ballroom room GMP production suites, QC lab, GMP warehouse, and offices, providing Wheeler’s customers with master cell banking, drug substance manufacturing, testing, and release services.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !